Jump to content

Methyldihydromorphine

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by 86.30.243.179 (talk) at 19:50, 19 October 2012. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Methyldihydromorphine
Clinical data
Other namesDihydroheterocodeine
ATC code
  • none
Legal status
Legal status
Identifiers
  • (5α,6α)-6-methoxy- 17-methyl- 4,5-epoxymorphinan- 3-ol
CAS Number
PubChem CID
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC18H23NO3
Molar mass301.38 g/mol g·mol−1
3D model (JSmol)
  • CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](CC4)OC
 ☒NcheckY (what is this?)  (verify)

Methyldihydromorphine (Dihydroheterocodeine)[1] is a semi-synthetic opioid drug developed in Germany in 1936, controlled under both domestic law and UN conventions because of its possible potential for abuse. Methyldihydromorphine is related to heterocodeine and is not a synonym for dihydrocodeine, and its structure suggests that it is six to nine times stronger than morphine and 72 times stronger than dihydrocodeine.

References

  1. ^ US Patent 2104058